Good to see this discussion. To be very frank
1). When I was reading up like mad, learning the ropes - I was most excited by DCF. As a concept it was really fascinating. Applying it was tough. As others have mentioned, its a dangerous tool in the hands of a novice. I liked Glenmark a lot in 2007/08 timeframes. I thought the business model had predictability built in it. 3 In-licensed molecules were bringing in/and going to bring in $69 mn additionally for the next many years till drug discovery. DCF analysis with this additional $69 million (that by the way went straight to the bottomline) showed it as cheap by half, with conservative discounting 15% plus, if I remember correctly. All other valuation measures showed it up as cheap. I went for the kill:)
2). For something like a year, I was overjoyed with the results. The stock doubled in less than 5-6 months. It went from 220+ levels to 400+ levels. everything looked rosy for this company. I thought I have latched on to a real long -term winner, never to let go kind of business at very cheap levels.
3). Suddenly one of the MNCs discontinued further research on a stage 3 molecule, citing some adverse side effect studies or something like that. Stock took some hit, but I was sanguine…so what others in the pipeline would come up. 3-6 months later another molecule was aborted. Suddenly 2 of the 3 in-licnsed molecules are out. The whole outlook on the company changed…prices crashed…the stock retraced itself to almost where I had picked it up.
4). Lesson for me - a) You cannot take predictability as guaranteed in R&D and Hi-tech businesses b) DCF works best only when there is a complete predictability in earnings/cashflows - however conservative your assumptions might have been. Even a 20% growth with 15% discounting will go for a six if predictability goes out.
5). Realised DCF has very little practical use for me - in making/swinging my investment decisions. At best it is just another valuation tool among others.
6). Realised what the Gurus meant when they say - You don’t need complicated modeling to tell you the intrinsic value of a business. if there is good Value, that will SCREAM out at you! Margin of Safety will be so high …as to be self evident.
7). We don’t find too many such situations -of under-valuedness screaming out at you - but sometimes you do. When the whole market crashes…that is obviously those times…like in 2009 Mar timeframes.
8). But even where markets are going nowhere, like say in 2010-11 timeframes, you come across situations where the Value just screams at you. We have to be very choosy, and develop a refined feel for under-valuedness. Something that among our friends I see Ayush Mittal very good at, Hitesh Patel(probably writes more often at ValuePickr/TED than he updates his blog) goes one better - to spot and be early in such opportunities!
We didn’t have any doubts about screaming UNDERVALUATION for
Manjushree -@30-40
Mayur Uniquoters - @220
Ajanta Pharma -@180 (Hitesh’s find; I got in later)
Astral Poly Technik -@120 (Again Hitesh/Ayush’s find; I got in slightly later)
Avanti Feeds -@ 35 (just 4-5 months back) ; quotes 120 now. I missed this entirely despite pointers from Ayush to look at it, look at it, mujhe to bahut accha lag raha hain!!
Now developing that sense of that UNDERVALUATION is the skill. It’s more an ART form. The number crunching and modeling will not take us there. The numbers and modeling are there for us more to AVOID mistakes!
Ayush and Hitesh, and a couple of other seniors have helped/keep helping me develop this feel slowly. They have helped me relax my theoretical thresholds (this was very very important for me). They have helped me see a few things that work fast in the market. They have certainly made me more practical - especially to appreciate that Excellent Businesses don’t sprout overnight. They mature from Good Businesses, achieve scale - economies of scale start kicking in, gradually improve efficiencies, to become better businesses, to hopefully Excellent businesses. Some of them fail to go to the next level, along the way!
They have helped me see clearly what they always maintained - There is Money to be made in every market. You need to keep getting better at the Science part of it to eliminate mistakes, but more importantly develop the ART side - spot what makes the Winners stand out from the average Joes - and sometimes Valuations will just SCREAM out at you.
Start taking a piece of that ACTION -even with incomplete information! Information will never be complete. Work very hard at gathering all you can, and question all you can, but build your own hypothesis for the Investment, keep moving and refining it with time with performance, with every new information set that comes in.
PI Industries is one such opportunity. Astral Poly Technik is another in my books. PI to an extent we have been able to transfer that conviction to a larger set of fellow investors -becaue of the great early work put in by Mahesh, Hitesh in confirming the promise, and then us collaborators taking the homework to the next level.
I may be wrong, but Astral is another extraordinary story in the making. Somehow fellow investors are unable to fully appreciate the power of the size of the opportunity before it, the power of the dominant position that it has - growing at 40% is no joke (everyone keeps talking of competition…how much has that affected/stopped Astral from growing) even when everyone is saying Realty and Infra is slowing. There are developments in the pipeline 2-3 years away which can propel the company a few levels higher, very fast. And next 2-3 years, it will have an unchallenged go. Its not easy to transfer that conviction…simply because this is an ART…that -something special- can’t be deciphered from the numbers, strictly speaking!
Those new to ValuePickr forums (and interested in discussions of this nature) are nudged to read the Capital Allocation thread in conjunction with this. I have a sense that helps you think about the ART side more concretely!